These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37205822)

  • 1. Role of Intrinsic Pathway in Coagulation After Use of Activated Prothrombin Complex Concentrate in Neonatal Cardiac Surgery.
    Kahntroff S; Hollander K; Stewart K; Tanaka KA
    Anesth Analg; 2023 Jun; 136(6):e39-e40. PubMed ID: 37205822
    [No Abstract]   [Full Text] [Related]  

  • 2. COMPARING THE EFFECTIVENESS OF CONCENTRATE OF ALL PROTHROMBIN COMPLEX FACTORS WITH RECOMBINANT HUMAN COAGULATION FACTOR VIIa IN THE TREATMENT OF BLEEDING AFTER CARDIAC SURGERY.
    Zagórski M; Sejboth J
    Pol Merkur Lekarski; 2023; 51(5):448-455. PubMed ID: 38069844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational and timely haemostatic interventions following cardiac surgery - coagulation factor concentrates or blood bank products.
    Tang M; Fenger-Eriksen C; Wierup P; Greisen J; Ingerslev J; Hjortdal V; Sørensen B
    Thromb Res; 2017 Jun; 154():73-79. PubMed ID: 28437748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of factor VIII--bypassing activity of activated prothrombin complex concentrate, prothrombin complex concentrate, and factor VIIa in the plasma of patients with factor VIII inhibitors: thrombin generation test in the presence of collagen-activated platelets.
    Sultan Y; Loyer F
    J Lab Clin Med; 1993 Mar; 121(3):444-52. PubMed ID: 8445292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro: Factor Concentrates are Essential for Hemostasis in Complex Cardiac Surgery.
    Ghadimi K; Welsby IJ
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):558-564. PubMed ID: 29217233
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary embolism after sequential use of recombinant factor VIIa and activated prothrombin complex concentrate in a factor VIII inhibitor patient.
    Rosenfeld SB; Watkinson KK; Thompson BH; Macfarlane DE; Lentz SR
    Thromb Haemost; 2002 May; 87(5):925-6. PubMed ID: 12038803
    [No Abstract]   [Full Text] [Related]  

  • 7. Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series.
    Schultz NH; Lundblad R; Holme PA
    J Med Case Rep; 2018 May; 12(1):138. PubMed ID: 29764497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors.
    Matino D; Makris M; Dwan K; D'Amico R; Iorio A
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD004449. PubMed ID: 26677005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prohemostatic Activity of Factor X in Combination With Activated Factor VII in Dilutional Coagulopathy.
    Takeshita S; Ogawa S; Nakayama Y; Mukai N; Nakajima Y; Mizobe T; Sawa T; Tanaka KA
    Anesth Analg; 2019 Aug; 129(2):339-345. PubMed ID: 30320649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contact activation and factor VII after the use of an activated prothrombin complex concentrate (FEIBA) in hemophiliacs with inhibitors.
    Mariani G; Bouma BN; Mazzucconi MG; Avvisati G; Di Nucci GD; Corrao D; Mandelli F
    Thromb Res; 1983 Aug; 31(3):475-88. PubMed ID: 20218003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-factor prothrombin complex concentrate and hemostasis after high-risk cardiovascular surgery.
    Tanaka KA; Mazzeffi MA; Grube M; Ogawa S; Chen EP
    Transfusion; 2013 Apr; 53(4):920-1. PubMed ID: 23565996
    [No Abstract]   [Full Text] [Related]  

  • 12. Activated Factor 7 Versus 4-Factor Prothrombin Complex Concentrate for Critical Bleeding Post-Cardiac Surgery.
    Mehringer SL; Klick Z; Bain J; McNeely EB; Subramanian S; Pass LJ; Drinkwater D; Reddy VS
    Ann Pharmacother; 2018 Jun; 52(6):533-537. PubMed ID: 29332420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding.
    Economou M; Teli A; Tzantzaroudi A; Tsatra I; Zavitsanakis A; Athanassiou-Metaxa M
    Haemophilia; 2008 Mar; 14(2):390-1. PubMed ID: 18194305
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with factor VIII deficiency and a factor VIII inhibitor.
    Chavin SI; Siegel DM; Rocco TA; Olson JP
    Am J Med; 1988 Aug; 85(2):245-9. PubMed ID: 3135752
    [No Abstract]   [Full Text] [Related]  

  • 15. Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery.
    Rao VK; Lobato RL; Bartlett B; Klanjac M; Mora-Mangano CT; Soran PD; Oakes DA; Hill CC; van der Starre PJ
    J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1221-6. PubMed ID: 25281040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes Following Three-Factor Inactive Prothrombin Complex Concentrate Versus Recombinant Activated Factor VII Administration During Cardiac Surgery.
    Harper PC; Smith MM; Brinkman NJ; Passe MA; Schroeder DR; Said SM; Nuttall GA; Oliver WC; Barbara DW
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):151-157. PubMed ID: 29217234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant VIIa concentrate in the management of bleeding following prothrombin complex concentrate-related myocardial infarction in patients with haemophilia and inhibitors.
    Hough RE; Hampton KK; Preston FE; Channer KS; West J; Makris M
    Br J Haematol; 2000 Dec; 111(3):974-9. PubMed ID: 11122162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated 4-Factor Prothrombin Complex Concentrate as a Hemostatic Adjunct for Neonatal Cardiac Surgery: A Propensity Score-Matched Cohort Study.
    Navaratnam M; Mendoza JM; Zhang S; Boothroyd D; Maeda K; Kamra K; Williams GD
    Anesth Analg; 2023 Mar; 136(3):473-482. PubMed ID: 36729967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prothrombin complex concentrate vs. fresh frozen plasma in adult patients undergoing heart surgery - a pilot randomised controlled trial (PROPHESY trial).
    Green L; Roberts N; Cooper J; Agarwal S; Brunskill SJ; Chang I; Gill R; Johnston A; Klein AA; Platton S; Rossi A; Sepehripour A; Stanworth S; Monk V; O'Brien B
    Anaesthesia; 2021 Jul; 76(7):892-901. PubMed ID: 33285008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.
    Tomokiyo K; Nakatomi Y; Araki T; Teshima K; Nakano H; Nakagaki T; Miyamoto S; Funatsu A; Iwanaga S
    Vox Sang; 2003 Nov; 85(4):290-9. PubMed ID: 14633255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.